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Abstract
Background: The field of plasmid-based functional proteomics requires the rapid assay of proteins expressed
from plasmid libraries. Automation is essential since large sets of mutant open reading frames are being cloned
for evaluation. To date no integrated automated platform is available to carry out the entire process including
production of plasmid libraries, expression of cloned genes, and functional testing of expressed proteins.
Results: We used a functional proteomic assay in a multiplexed setting on an integrated plasmid-based robotic
workcell for high-throughput screening of mutants of cellulase F, an endoglucanase from the anaerobic fungus
Orpinomyces PC-2. This allowed us to identify plasmids containing optimized clones expressing mutants with
improved activity at lower pH. A plasmid library of mutagenized clones of the celF gene with targeted variations
in the last four codons was constructed by site-directed PCR mutagenesis and transformed into Escherichia coli.
A robotic picker integrated into the workcell was used to inoculate medium in a 96-well deep well plate,
combining the transformants into a multiplexed set in each well, and the plate was incubated on the workcell.
Plasmids were prepared from the multiplexed culture on the liquid handler component of the workcell and used
for  in vitro transcription/translation. The multiplexed expressed recombinant proteins were screened for
improved activity and stability in an azo-carboxymethylcellulose plate assay. The multiplexed wells containing
mutants with improved activity were identified and linked back to the corresponding multiplexed cultures stored
in glycerol. Spread plates were prepared from the glycerol stocks and the workcell was used to pick single
colonies from the spread plates, prepare plasmid, produce recombinant protein, and assay for activity. The
screening assay and subsequent deconvolution of the multiplexed wells resulted in identification of improved CelF
mutants and corresponding optimized clones in expression-ready plasmids.
Conclusion: The multiplex method using an integrated automated platform for high-throughput screening in a
functional proteomic assay allows rapid identification of plasmids containing optimized clones ready for use in
subsequent applications including transformations to produce improved strains or cell lines.
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Background
The field of plasmid-based functional proteomics utilizes
full-length cDNA plasmid libraries as a source of clones
for evaluation of protein function by in vitro transcription/
translation or in vivo expression methods. Since the librar-
ies are composed of several thousand gene variants, auto-
mation of the screening process is essential. To date, a
number of automated systems have been developed to
assist in screening [1-11], but no single integrated plat-
form exists to carry out the entire process from production
of plasmid libraries to functional testing of expressed pro-
teins for large sets of clones. The cell-free system
employed by Betton [3] to test the expression level of the
protein by in vitro transcription/translation from PCR
product prior to cloning the gene results in a protein opti-
mized for expression. However, the optimized PCR prod-
uct identified by this system remains to be isolated and
purified manually, then cloned by conventional non-
automated methods to evaluate expression of soluble,
folded protein in vivo. The automated protein preparation
platform described by Vinarov and Markley [11] is useful
for large-scale production of labeled protein for NMR
structural analysis from plasmids obtained via small-scale
screening of selected target ORFs for expression levels and
solubility. However, the advantage of an automated plas-
mid-based platform is the ability to obtain a large number
of expression-ready plasmid sets that contain optimized
clones for automated transformation to produce
improved strains or cell lines. Expression of appropriately
folded, soluble protein in vitro or  in vivo provides the
means to screen for an optimized clone already placed in
a plasmid and capable of yielding a functional protein.
We are currently developing an integrated plasmid-based
functional proteomic workcell to automate all required
tasks: producing cDNA libraries, picking colonies, isolat-
ing plasmid DNA, transforming yeast and bacteria,
expressing proteins, and performing functional assays.
The development of the liquid handler component for
automated 96-well plate plasmid preparation on the
workcell has been described previously [12]. The inte-
grated automated large-scale liquid handler adaptation
described in this paper produces plasmids of sufficient
quantity and quality for use in mutagenesis strategies for
open reading frame optimization and in generating
unique expression-ready cDNA libraries to develop
improved strains and cell lines.
The cost of using automated molecular biology tech-
niques in high-throughput recombinant protein screens
can be prohibitively expensive. A multiplexed format
reduces the time and cost of producing recombinant pro-
teins from large-scale plasmid preparations by decreasing
the number of wells to be screened and the amount of rea-
gents needed. Here we present an automated multiplex
method made possible by integration of a robotic colony
picking component onto an automated workcell platform
capable of high-throughput screening of a plasmid library
expressing mutants of the endoglucanase CelF to obtain
clones giving rise to proteins with improved activity at
lower pH and stability at higher temperature. Enzymes
such as CelF are capable of digesting plant cell wall
polysaccharides and therefore have potential industrial
application in breaking down plant biomass for use in
fuel ethanol production [13,14]. The multiplex method
involves an initial screening of a multiplexed culture that
contains a mixture of clones in order to identify those giv-
ing rise to in vitro expressed improved mutant proteins.
Individual clones corresponding to these improved
mutants are then isolated by picking single colonies from
the multiplexed cultures, producing plasmid DNA from
the picked colonies and expressing protein in automated
in vitro transcription/translation reactions to identify the
mutant with improved activity on a plate-based func-
tional assay.
Results
Mutagenesis
Targeted mutagenesis of the last four codons of the celF
gene was initially accomplished by creating a PCR primer
set with the reverse primer (anti-sense strand) containing
any nucleotide in the first and second positions and a
pyrimidine in the last position (NNY). Consequently the
sense strand contains the complementary NNR motif
where R is a purine. This strategy generates a library of
open reading frames that code for 14 of the possible 20
amino acids at each of the last four positions in the CelF
mutants, or 144 = 38,416 possible combinations. Phe, Tyr,
His, Asn, Asp, and Cys are not possible since they have
only NNY codons. Also, because of the degeneracy of the
code, almost every amino acid is represented by several
codons (synonyms). In the NNR strategy the amino acids
with the most synonyms are leucine and arginine.
Although the amino acids with more synonyms have a
theoretically greater likelihood of appearing, it is possible
that they do not improve the activity of the mutant and
may even eliminate activity and thus are not seen in the
screening process.
A subsequent large-scale screening run was conducted in
which the site-directed PCR mutagenesis strategy was
modified to obtain NNY as well as NNR codons in the
sense strand. This was accomplished by producing PCR
primers with an NNR motif in the anti-sense strand in
addition to the primers with the NNY motif. A library of
open reading frames is obtained from the NNR primers
coding for the six amino acids having only NNY codons
and also for the nine other amino acids having both NNY
and NNR codons. So the NNY codon strategy gives a total
of 154 = 50,625 possible CelF variants. Together with theProteome Science 2006, 4:10 http://www.proteomesci.com/content/4/1/10
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38,416 possible CelF variants from the NNR codon strat-
egy this gives a total of 89,041 theoretically possible CelF
variants.
The forward primer contained the CACC sequence in
front of the ATG start codon to allow the library of muta-
genized clones to be moved into the pENTR D TOPO vec-
tor system directionally. The resulting library was
transformed into E. coli cells, spread onto selective plates
and incubated overnight. In the initial NNR screen,
approximately 10 to 80 colonies were obtained on each of
the 100 plates in this set when each plate was spread with
one 25-µL competent cell transformation. In the subse-
quent large-scale NNR plus NNY screening run, 178
spread plates were prepared from the transformation reac-
tions containing clones with NNY codons and 262 spread
plates were prepared from the transformation reactions
containing clones with NNR codons. One 25-µL compe-
tent cell transformation was used for each spread plate.
Multiplexed colony picking
Colony picking was performed on the automated work-
cell using the workcell picker (Figure 1 #4) to give multi-
plexed wells on a 96-well deep well culture plate. The first
run entailed picking eight colonies from the spread plates
to inoculate each well of an ABgene deep well block con-
taining 1.6 mL of TB KAN 25 medium, giving a total of
768 clones for one plate (8 per well × 96 wells). From the
768 clones screened in this run, five (5) multiplexed cul-
tures with improved activity were identified. The subse-
quent large-scale run entailed picking 80 colonies to
inoculate each well of three 96-well deep well blocks and
4 colonies to inoculate each well of another 96-well block,
giving a total of 23,424 clones screened (3 × 96 × 80) plus
(96 × 4). Of this total, 9,486 were taken from colonies
containing NNY clones and 13,938 were taken from colo-
nies containing NNR clones. The number of clones
screened was increased to verify the high-throughput
capability of the automated platform.
Integration of the picking operation onto the robotic
workcell permits automated multiplexing, which con-
serves reagents and time. After colony picking was per-
formed, the resulting multiplexed cultures were incubated
overnight and processed using the plasmid preparation
protocol on the liquid handler of the workcell (Figure 1
#9). Inserts were directionally cloned into pENTR D
TOPO using topoisomerase ligation, then into pEXP-1
DEST vector via LR clonase reaction and transformed into
TOP 10 E. coli cells [12]. The resulting multiplexed plas-
mid library with mutagenized inserts was used for in vitro
transcription/translation.
Screening of multiplexed mutants
The expressed CelF proteins from the multiplexed tran-
scription/translation reactions were assessed for cellulase
activity at several pH levels using an automated azo-CMC
plate assay. The results at pH 5.8 showed several cleared
zones after incubation for 10 hours at 37°C, indicating
cellulase activity (Figure 2). It can be determined from the
Multiplexed CelF azo-CMC screening plate Figure 2
Multiplexed CelF azo-CMC screening plate. In vitro expressed 
protein from multiplexed plasmid preparation was spotted 
onto agar plate containing azo-CMC (pH 5.8). Wells are 
identified by the row (letter) and column (number) on the 
azo-CMC plate. B11, C12, G2, G11 and H12 showed great-
est activity and were selected for separation into individual 
clones (see Figures 6 and 7).
Diagram of the robotic workcell (shown without biocontain- ment hood) Figure 1
Diagram of the robotic workcell (shown without biocontain-
ment hood). Position #1A: Track 1; #1B: Track 2; #2A: 
StackLink active stacker (Track 1); #2B: StackLink active 
stacker (Track 2); #3: 4-axis Hudson Plate Crane EX; #4: 
BioRad VersArray colony picker/arrayer; #5: PCR thermal 
cycler with motorized heated lid; #6: UV/VIS plate reader 
using KC4 software; #7: ABgene 300 plate sealer using foil 
tape; #8: Brandel RS3000 plate sealer using porous tape; #9: 
liquid handler with centrifuge; #10: Hudson micro10 filler; 
#11: Hudson track-based sterile plate aspirator; #12: auto-
mated incubator; #13: passive stackers; #14: computer and 
monitor: #15: barcode reader; #S1-S6: StopLink plate posi-
tions.Proteome Science 2006, 4:10 http://www.proteomesci.com/content/4/1/10
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diameter and intensity of the cleared zones on the plate
that protein from wells B11, C12, G2, G11, and H12 had
elevated activity at this pH. The negative control placed on
the plate (pUC19) in well E1 showed no cellulase activity.
Activities of positive controls, wild-type (CelF #5) and an
improved mutant (CelF #62) obtained previously [12],
are shown in wells B3 and C5, respectively.
Control experiments were performed to determine the
effect of increasing amounts of CelF mutants in a multi-
plexed well or increasing numbers of multiplexed colo-
nies on assay sensitivity. Figure 3 illustrates that as the
amount of an individual active CelF mutant spotted on
the azo-CMC plate is increased from 27.7 to 277 ng, the
activity measured by the diameter of the cleared zone pro-
duced on the plate increases in a linear fashion. The
cleared zones on the azo-CMC plate at pH 5.8 are shown
in the inset at the top of the graph (incubation at 10
hours, 37°C). In addition, if the number of colonies mul-
tiplexed in a well is increased relative to an individual
CelF mutant, the activity of that mutant is still detectable.
Figure 4 depicts the activities obtained when an individual
active CelF mutant is added to a mixture containing an
increasing number of background colonies multiplexed as
described in this paper, from no background colonies
(active mutant alone) to 96 background colonies per well.
The cleared zones on the azo-CMC plate at pH 5.8 are
shown in the inset at the bottom of the graph (incubation
at 10 hours, 37°C).
Identification of individual clones
The multiplexed wells containing mutants with improved
activity that were identified on the multiplexed azo-CMC
screening plate (Figure 2) were linked back to the corre-
sponding multiplexed cultures stored in glycerol. The
identified glycerol stocks were spread on LB AMP 50
plates and single colonies from these plates were picked
by the workcell colony picker into a 96-well plate to iso-
late individual clones from the selected high-activity
wells, B11, C12, G2, and G11. The single colonies were
picked into TB AMP 50 medium and incubated for 20
hours. In the automated picking process, the colony
picker was programmed to select colonies between 0.2 to
10 millimeters in size. This restriction was fixed for a given
run but could be reprogrammed if necessary. To deter-
mine how this automated picking process compared with
manual picking by an individual who has greater leeway
in selecting colonies and who may attempt to optimize
the variety of colonies being picked, a set of colonies was
also picked manually.
The manual picking was performed using 4 groups of 24
wells on the 96-well plate and taking 24 colonies corre-
sponding to each of the identified wells (process outlined
in Figure 5). After expansion of the 96-well plate into four
24-well plates, large-scale plasmid preparation was per-
formed on the liquid handler and the resulting plasmids
were eluted into one 96-well Matrix collection plate. The
plate was moved to the Bio-Tek UV/VIS microplate reader
and the absorbance at 260 nm of each well was adjusted
Diameter of cleared zone plotted as a function of increasing concentration of an individual improved CelF mutant Figure 3
Diameter of cleared zone plotted as a function of increasing concentration of an individual improved CelF mutant. One, 3.0, 5.0 
and 10.0 µL of a 27.7 ng/µL solution of F9MP mutant (27.7, 83.1, 139 and 277 ng, respectively) were spotted on an azo-CMC 
plate at pH 5.8. The resultant cleared zones are pictured in the inset above the graph (incubation at 10 hours, 37°C).Proteome Science 2006, 4:10 http://www.proteomesci.com/content/4/1/10
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to 1.0 (equivalent to a concentration of 0.05 µg/µL) by
diluting with Qiagen EB buffer on the liquid handler deck
using the liquid handler pipets and buffer from the cold
block on the deck. In vitro transcription/translation reac-
tions were performed using the entire plate of plasmids.
Protein was spotted on four azo-CMC plates at pH 4.0,
4.5, 5.0, and 5.8. Protein heated to 50°C for 1 hour was
spotted on a fifth plate (at pH 5.8). An improved CelF
enzyme was isolated from each of the identified multi-
plexed wells (Figure 6). Individual mutants are identified
by row (letter) and column (number) on the plate and by
"MP" indicating they were manually picked. Columns 1–
3 on each plate were picked from colonies corresponding
to multiplexed well B11 (see Figure 2) (high activity vari-
ant F2MP boxed in purple is in row F and column 2), col-
umns 4–6 from multiplexed well C12 (high activity
variants are E5MP boxed in yellow and F5MP boxed in
blue), columns 7–9 from multiplexed well G2 (high activ-
ity were E7MP in green and F9MP in orange), columns
10–12 from multiplexed well G11 (F12MP in pink).
Clones F2MP, F5MP, F9MP, and F12MP had activity at
lower pH than wild-type CelF. Clones F2MP, F9MP, and
F12MP were also stable after heating to 50°C for 1 hour.
F9MP (boxed), which exhibits the most exceptional activ-
ity, was shown to have the same sequence as B9MP,
C9MP, and E8MP (all not boxed), which all exhibit activ-
ity similar to F9MP. The boxed mutants were selected for
Western blot analysis.
The same multiplexed glycerol stock spread plates from
which colonies had been picked manually were also used
for automated picking into a 96-well plate (see process in
Figure 5). The colonies were picked and identified as con-
trols or samples. Expansion of the 96-well plate into the
first of the four 24-well plates involved inoculation on the
workcell with 84 colonies from five of the identified high-
activity multiplexed stocks (B11, C12, G2, G11, H12).
Control cultures were placed in 12 of the 24 wells (boxed
at top left of Figure 7), including pUC19 (negative control
for expression), GUS gene (positive for expression; nega-
tive for activity), wild-type CelF #5 and improved mutant
CelF #62 [12] (positive controls for activity). The 24-well
process was repeated for three more plates. After expan-
sion of the 96-well plate into the four 24-well plates,
large-scale plasmid preparation was performed on the liq-
uid handler and the resulting plasmids were combined
into a 96-well Matrix collection plate. Plasmid DNA con-
centrations were adjusted to 0.05 µg/µL using the A260
reading from the UV/VIS microplate reader so all clones
were present in sufficient quantity for consistent expres-
sion, and then in vitro transcription/translation reactions
were performed for the entire plate of plasmids. The
resulting set of recombinant proteins was spotted on azo-
CMC plates at pH 4.0, 4.5, 5.0, and 5.8. A fifth plate (at
pH 5.8) was spotted with protein heated at 50°C for 1
hour. Results were similar to those for the manual picking
procedure and indicated that an improved CelF protein
was present in each of the identified multiplexed wells.
Two mutants having high activity at lower pH and show-
ing stability at elevated temperature (G4AP boxed in
brown, G12AP boxed in red) were identified (Figure 7) in
the automated picking process ("AP" indicates clones
from this process). Several other CelF variants were seen
that had high activity at pH 5.8 and 5.0 but not at pH 4.5
or 4.0 (for example, C1AP and E2AP boxed in aqua). One
mutant (H1AP in aqua) had activity only at pH 5.0 and
two variants were not stable after heating to 50°C (E2AP
and D6AP in aqua). Several clones were aberrant because
no insert was detected (B8AP), no plasmid DNA was
recovered (H10AP) or an unsuccessful recombinational
event occurred (F9AP) as seen when the plasmids were
subjected to BsrGI restriction analysis (data not shown).
Sequences of mutants
Sequences for the mutagenized clones that gave CelF var-
iants with improved activity at lower pH are listed in Table
1. Sequencing results for the manually picked clones iden-
tified five unique sequences from the 768 clones origi-
nally picked into the multiplexed wells. Clones G12AP
and G4AP selected in automated picking had the same
sequence as F2MP and F9MP, respectively, from manual
picking. The CelF variant (F9MP/G4AP) that had the
greatest activity at lower pH and was stable at elevated
temperature also contained a point mutation at amino
acid 213 in addition to the four amino acid changes at the
C-terminus generated by mutagenizing the last four
codons of the celF gene. A CelF mutant, C7HTS ("HTS"
Detection of activity of an individual CelF mutant in a multi- plexed mixture as number of colonies multiplexed per well  increases Figure 4
Detection of activity of an individual CelF mutant in a multi-
plexed mixture as number of colonies multiplexed per well 
increases. Activity contributed by an individual CelF mutant 
(F9MP) is plotted as a function of number of background col-
onies multiplexed as described in Methods. The cleared 
zones on the azo-CMC plate at pH 5.8 are shown in inset at 
bottom (10 µL spotted; incubation at 10 hours, 37°C).Proteome Science 2006, 4:10 http://www.proteomesci.com/content/4/1/10
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Table 1: 
Clone Plate Sequence of CelF Terminal Codons pH 
Range
50°C, 1 
Hour 
Stability
Mutagenesis NNR NNR NNR NNR *
WT #5 CONTROL From single 
96-clone 
screen
AAT GCT AGA CCA GGA TTC TAA 5.0–5.8 Moderate
Asn Ala Arg Pro Gly Phe *
#62 CONTROL From single 
96-clone 
screen
AAT GCT CCA GTA CGG GAA TAA 5.0–5.8 Moderate
Asn Ala Pro Val Arg Glu *
COLONY PICKING Variants with High Activity at Low pH
MAN AUTO
E7 From G2 well 
of 768-clone 
multiplex 
screen
AAT GCT TTA TAA 4.0–5.8 Not Stable
Asn Ala Leu *
F2 G12 From B11 
well of 768-
clone 
multiplex 
screen
AAT GCT CAA TGG ACA CCA TAA 4.0–5.8 Moderate
Asn Ala Gln Trp Thr Pro *
F9 φ G4 φ From G2 well 
of 768-clone 
multiplex 
screen
AAT GCT ATG CCA ACG TTA TAA 4.0–5.8 Very Stable
Asn Ala Met Pro Thr Leu *
F12 From G11 
well of 768-
clone 
multiplex 
screen
AAT GCT CCA TAA 4.0–5.8 Moderate
Asn Ala Pro *
HTS Mutagenesis NNR/Y NNR/Y NNR/Y NNR/Y *
C7 From Plate 2 
well of 
23,424- clone 
multiplex 
screen
AAT GCT GGG TTA GAA TAG TAA 4.0–5.8 Very Stable
Asn Ala Gly Leu Glu * *
φ An additional Thr to Ser mutation at amino acid position 213 in F9 and G4 clonesProteome Science 2006, 4:10 http://www.proteomesci.com/content/4/1/10
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denotes high-throughput screen), that was active at
restrictive pH 4.0 and very stable to heating at elevated
temperature, with a sequence differing in the last four
amino acids from those in the mutants obtained previ-
ously, was identified in the large-scale run from the NNY
plus NNR mutagenesis strategy. C7HTS also had a prema-
ture stop codon, shortening the sequence by one amino
acid.
Western blot analysis of the expressed proteins is provided
in Figure 8. Wild-type CelF (control #5) and variants of
the same length as wild-type give a band at 47.7 kD. E5MP
in the first lane at 52.6 kD had a mutated stop codon
resulting in a CelF variant with 54 more amino acids than
wild-type (486 versus 432) (sequence not shown). It had
decreased stability after heating and some cellulase activ-
ity down to pH 4.5. The G4AP CelF variant, which was
shown to have the same sequence as F9MP, demonstrated
activity similar to F9MP in that it had greater stability after
heating than wild-type CelF and retained cellulase activity
down to pH 4.0. Variants F5MP, F12MP, F2MP and E7MP
all had activity at lower pH (4.0 or 4.5) but none was as
stable after heating as G4AP/F9MP. Variants H1AP, C1AP,
E2AP and D6AP demonstrated less cellulase activity than
wild-type CelF. Control #62 is an improved CelF variant
obtained previously [12]. No cellulase activity and, in fact,
no CelF variants were obtained from locations B8AP,
F9AP and H10AP. Restriction digest analysis (data not
shown) showed primer-dimer insertion, a recombina-
tional event or no plasmid was present in those cases,
respectively.
Figure 9 provides a comparison of the activity of wild-type
CelF and CelF mutants, #62, F9MP, and C7HTS, at pH
4.0. C7HTS from the large-scale screen demonstrates the
greatest activity compared with all other clones obtained
to date. The Western blot analysis in the inset at the top
shows that the improved CelF variants C7HTS, F9MP and
#62 were present at the same concentration for all com-
parisons.
Discussion
The multiplex method described here using an automated
plasmid-based workcell allows large-scale expression and
rapid functional analysis of proteins using an azo-CMC
plate assay to evaluate enzyme activity. Integration of the
robotic colony picker onto the automated workcell plat-
form permits the complete process from colony produc-
tion to protein analysis to be performed on a single
robotic platform. Our first application of this integrated
workcell was the screening of a library of mutagenized celF
clones. The celF cDNA [15,16] used for the mutagenesis
strategy was initially provided in the pBlueScript® vector
with a polyhistidine (6 × His) tag at the amino terminus
for purification by binding to Ni beads, and containing a
regular T7 promoter for in vivo expression in bacteria. Cel-
lulase activity was evaluated using a liquid-based p-nitro-
phenol assay. Our intention was to use the Invitrogen
Gateway® recombinational cloning system to completely
automate plasmid production and process a larger
number of clones. A modified T7 promoter was employed
for optimum in vitro transcription/translation and, in
addition, the 6 × His tag was placed at the carboxy termi-
nus to purify primarily full-length expressed proteins. As
an accommodation for the automated platform, a plate-
based azo-CMC assay was developed instead of the liquid-
Schematic depicting workcell protocols and plates used in  the automated process for separating multiplexed muta- genized clones into individual clones (involving either the  manual or the robotic colony picking step) Figure 5
Schematic depicting workcell protocols and plates used in 
the automated process for separating multiplexed muta-
genized clones into individual clones (involving either the 
manual or the robotic colony picking step).Proteome Science 2006, 4:10 http://www.proteomesci.com/content/4/1/10
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based assay. However, addition of the 6 × His tag to the
carboxy terminus eliminated cellulase activity in the liq-
uid-based p-nitrophenol assay. Moving the tag back to the
amino terminus gave activity on the azo-CMC plate assay,
suggesting that the carboxy terminus of CelF may play an
important functional role. Efforts were therefore focused
on modifying the last four amino acids at this end of the
enzyme to maximize the effect on its activity.
We reasoned that mutation of four codons should provide
a large enough number of variants to obtain some with
improved activity but still give a manageable number of
clones that could be handled in a realistic time on the
automated platform. The NNR mutagenesis strategy tar-
geted to the last four amino acids at the carboxy terminus
of CelF and providing codons for 14 amino acids yielded
sufficient viable variants with improved activity so that
the initial run in which eight colonies were multiplexed
per well could identify five unique variants with improved
activity. If no optimized variant had been obtained, the
number of colonies multiplexed per well could have been
increased and/or the automated picking process could
have been repeated for rapid screening on the automated
platform. Although only 768 of the 38,416 theoretically
possible NNR mutagenized celF clones picked in the ini-
tial run were screened (2%), several improved clones were
obtained. In the subsequent NNR plus NNY mutagenesis
run, 23,424 of 89,041 or 26% of the theoretically possible
clones, 19% of the NNY clones and 36% of the NNR
clones, were screened. This strategy yielded at least one
additional CelF variant with exceptional activity. The
number of viable variants obtained and of colonies that
must be multiplexed will depend on a variety of factors,
including the gene being mutagenized and the mutagene-
sis strategy.
Sufficient plasmid can be produced by the workcell to
conduct repetitive protein expression reactions and func-
tional assays to rapidly identify multiplexed wells con-
taining CelF mutants with improved characteristics over
wild-type CelF. These multiplexed wells are then deconvo-
luted to identify individual clones. The assay for analysis
of the expressed proteins was developed keeping in mind
that a rapid qualitative measurement of the activity of the
recombinant CelF mutants is required. We chose an agar-
based gel-diffusion assay containing azo-CMC that was
readily adapted for high-throughput screening on a
robotic platform.
The need for sufficient protein for the functional pro-
teomic assays made it necessary to configure the workcell
so it produced highly concentrated and abundant plasmid
DNA. This was achieved by making quadruplicate prepa-
rations in 24-well plates with 5 mL of medium in each
well followed by elution and collection into one 96-well
Azo-CMC plate analysis of expressed proteins from manually  picked (MP) individual colonies Figure 6
Azo-CMC plate analysis of expressed proteins from manually 
picked (MP) individual colonies. Individual mutants are identi-
fied by row (letter) and column (number) on the plate and by 
method of picking. Columns 1–3 on each plate were picked 
from colonies corresponding to multiplexed well B11 (see 
Figure 2) (high activity variant F2MP is in row F and column 
2), columns 4–6 from C12 (high activity variants are E5MP 
and F5MP), columns 7–9 from G2 (E7MP and F9MP), col-
umns 10–12 from G11 (F12MP). Note that F9MP has the 
most exceptional activity. Replicates of F9MP activity at pH 
4.0 (incubated for 24 hours) are enlarged to better visualize 
cleared zones. Boxed mutants were selected for Western 
blot analysis (Figure 8) based on activity and stabilityProteome Science 2006, 4:10 http://www.proteomesci.com/content/4/1/10
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plate to give a final volume of 20 mL. The four plates that
were eluted into one 2D Matrix collection plate gave more
than four times the amount of plasmid previously
observed for one plate when using 1.6 mL of cultures [12].
As reported previously, one 96-well Matrix plate gave 5.35
µg per well [12], so for four plates the expected yield
would be over 21.4 µg. In the process described in this
paper, an average of 31.1 µg per well was obtained (data
not shown). However, the amount of starting culture
taken here was 20 mL, while in the earlier experiment the
amount of starting culture was 1.6 mL per plate (or 6.4 mL
if four plates were used). Quantities greater than the
amount used here exceed the capacity of the filter plates
causing the wells to become blocked so the wash solution
cannot be properly pulled through and the plasmid qual-
ity deteriorates.
Linking the multiplexed wells with improved CelF activity
back to the multiplexed glycerol stocks and isolating the
individual clones from the glycerol stock spread plates are
carried out in a completely automated fashion on the
workcell. For purposes of comparison, the initial colony-
picking operation was performed both manually and on
the workcell. Two improved mutants, F2MP and F9MP,
isolated by the manual picking process had the same
sequence as G12AP and G4AP, respectively, isolated by
the automated picking process. All the high-activity wells
that were separated out at the colony level gave rise to at
least one mutant with increased activity (F2MP/G12AP,
F5MP, F9MP/G4AP, F12MP). We initially selected eight
picks for each multiplexed well based on the expectation
that a large number of different mutants would be
obtained. If too many picks were combined, identification
of the individual mutants with increased activity might be
difficult. With eight picks no multiplexed high-activity
wells were seen in which more than one variant contrib-
uted to the increased activity, indicating eight picks per
well was enough to give optimized mutants of CelF while
being a manageable number for testing the protocols on
the automated platform. For other genes, no optimized
mutants might be found with eight picks per well. In such
cases the number of picks can be increased as needed on
the automated platform.
The control experiment, in which the amount of a known
variant (F9MP) with improved activity was increased and
the activity determined, demonstrates that in the range of
concentrations encountered, the activity on the azo-CMC
plate increases in a linear fashion as the amount of CelF
variant increases. In addition, if the number of colonies
multiplexed is increased relative to the amount of an indi-
vidual CelF variant in a multiplexed well, the activity of a
single variant can still be detected even if as many as 96
colonies are multiplexed in one well.
Azo-CMC plate analysis of expressed protein from roboti- cally picked individual colonies Figure 7
Azo-CMC plate analysis of expressed protein from roboti-
cally picked individual colonies. Individual mutants are identi-
fied by row (letter) and column (number) on the plate and 
method of picking (AP – automated picking). Controls are 
found in the first six locations in the top two rows. Boxed 
mutants were selected for Western blot analysis (Figure 8) 
based on activity at low pH and after heating. Colors and let-
ter/number identifiers correspond to those in Figure 8. Row 
G is enlarged in the inset at bottom to better visualize 
cleared zones.Proteome Science 2006, 4:10 http://www.proteomesci.com/content/4/1/10
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In vitro transcription/translation is expected to express
close to the theoretical maximum number of clones from
the mutagenesis strategy when the automated process is
run repetitively since it avoids the issues of folding, inclu-
sion body formation, or cell poisoning often found with
in vivo expression. When all plasmids in one group of 24
from the manual picking process were sequenced (from
multiplexed well C12), five unique sequences were found
among the 24 plasmids (three of the eight picked clones
were duplicates). Duplication is quite possible since sev-
eral clones were picked from the same transformation
plate. It is possible that some of the eight inserts picked at
the pENTR D TOPO stage were not cloned recombina-
tionally into the pEXP-1 DEST expression plasmid. Also
some of the pEXP-1 DEST clones might not have trans-
formed into the TOP 10 propagation cells. Transforma-
tion into TOP 10 chemically competent E. coli cells
without f' pilus avoids phage contamination and propa-
gates plasmids without expression from the T7 promoter
so expression of the clones does not affect survival of E.
coli cells. Competition might also cause loss of some
inserts. BsrGI restriction analysis was performed on the
sets of plasmid to determine the number of full-length
inserts present. It was found that from the 180 clones
picked from the spread plates (manual and automated
picking combined), 143 or 79% had a full-length or
nearly full-length insert (data not shown). Although there
is some insert loss, the automated workcell has the ability
to screen large numbers of mutagenized clones.
The quantity of protein produced in the in vitro transcrip-
tion/translation reaction appears to be less dependent on
the amount of plasmid than on the amount of reagent
mix used, as seen in the control well for the automated
run. A statistical evaluation (using manually picked clone
F9MP in all 96 wells) showed less variation in the protein
amount (COV = 13%; n = 24; avg = 1358 ng/25 µL reac-
tion) than the variation in the amount of plasmid (COV =
22%; n = 96; avg = 31.1 µg/well) from which it was
expressed (see inset at bottom of Figure 6). Protein assess-
ment showed the protein produced from a given well was
fairly consistent with the other 23 control wells examined
(COV for activity was 12%). It is possible that a maximum
amount of RNA message is produced from a threshold
level of plasmid. This suggests it is important to keep the
amount of reagent constant at a level sufficient for consist-
ent expression in the in vitro expression reactions, while
keeping the plasmid at the threshold level.
Randomizing the sequence at the end of the insert coding
for the last four amino acid positions at the carboxy termi-
nus of CelF provided mutants with a range of activities.
F2MP/G12AP was an interesting variant of CelF with
activity down to pH 4.0 and also higher activity at pH 5.8
than that of wild-type CelF. It had the same moderate sta-
bility as wild type after being heated at 50°C for 1 hour.
The sequence for this variant reveals the last four amino
acids are Gln Trp Thr Pro. F9MP/G4AP was the most
improved clone selected in the initial screen. It demon-
strated high activity down to pH 4.0 with much higher sta-
bility than wild-type CelF after heating to 50°C for 1 hour.
Further biochemical and crystallographic investigation of
this clone is underway. The clone also had a conservative
point mutation at amino acid 213, specifically a Thr to Ser
change, in addition to the change in the last four amino
acids to Met Pro Thr Leu resulting from the NNR mutagen-
esis strategy. This might help to account for its activity at
lower pH and its stability after heating. These two mutant
CelF enzymes of interest (F2MP/G12AP and F9MP/G4AP)
maintained the same total number of amino acids (412)
and both contained a Pro residue in the last four amino
acids similar to the wild-type CelF sequence. The point
mutation probably resulted from lack of fidelity of the Taq
DNA polymerase in the PCR reaction.
Two clones that ended in a truncated sequence, E7MP and
F12MP, had activity similar to wild type at the pH levels
tested, but had decreased thermal stability. The carboxy
terminus amino acid sequence for E7MP was truncated at
Leu by insertion of a stop codon, causing the last three
amino acids to be missing. The other truncated mutant
F12MP was moderately stable and ended in Pro. This CelF
mutant, containing only one amino acid of the last four,
demonstrated activity down to pH 4.0. Most of the
mutants with improved thermal stability and pH range
contained a proline among the last four amino acid posi-
tions. In the cellulase tunnel in the CelF structure that has
been described [17,18] the presence of proline among the
last four amino acids in the enzyme may facilitate sub-
strate access. Our results suggest that the C-terminus is
important to both thermal stability and activity at lower
pH.
Three clones (E5MP, E7MP, F12MP) were found whose
sequence contained a mutated TAA stop codon or in
which additions of nucleotides to the ORF led to longer
proteins, as seen in the Western blot (Figure 8; E5MP).
This may have been the result of errors in the oligomers.
None of these mutants had better thermal stability or
higher activity at any pH than wild-type CelF. This was in
accordance with the observation that adding a tag to the
C-terminus of CelF caused loss of cellulase activity.
The sequence of the CelF mutant with most improved
activity obtained to date, C7HTS, isolated from the NNY
plus NNR strategy in the 23,424-clone run also contained
amino acid substitutions in the last four positions that
resulted from NNR codons. No high-activity mutants
identified to date in this screen had amino acids in the last
four positions resulting from NNY codons. AlthoughProteome Science 2006, 4:10 http://www.proteomesci.com/content/4/1/10
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truncated, the C7HTS mutant had the highest activity on
the azo-CMC assay. We are continuing to investigate
amino acid substitutions resulting from the NNR plus
NNY strategy.
Conclusion
It was possible to identify and isolate individual improved
celF open reading frames from colonies picked from mul-
tiplexed sets of mutagenized clones of the celF gene. For
the celF gene, multiplexing of eight colonies per well was
sufficient to obtain five (5) unique improved CelF
mutants. Screening was performed in high-throughput on
a robotic workcell using an automated azo-CMC plate
assay to analyze the in vitro expressed proteins and iden-
tify optimized clones from the mutagenized libraries. In
vitro expression for this gene avoided the issues frequently
seen with in vivo expression. The combined operations of
colony picking from multiplexed plates, large-scale plas-
mid preparation, in vitro transcription/translation, and
azo-CMC plate protein assay, followed by isolation and
analysis of individual clones, were conducted on an auto-
mated platform to screen CelF mutants resulting from a
targeted clone mutagenesis strategy. For comparison pur-
poses, both manual and automated colony picking oper-
ations were conducted. Both led to identification of the
same high-activity thermally stable clones from the multi-
plexed screening plate of CelF mutants. This demonstrates
that standard molecular biological techniques can be
applied to high-throughput functional proteomic analysis
when placed on a plasmid-based robotic workcell using
the automated operations described here for identifica-
tion and isolation of an improved clone from a multi-
plexed mixture of clones. The multiplex method using an
integrated automated platform for high-throughput
screening in a functional proteomic assay allows rapid
identification of plasmids containing optimized clones
ready for use in subsequent applications including trans-
formations to produce improved strains or cell lines.
Methods
Plasmid-based proteomic workcell
The ProLink Express™ workcell (Figure 1) was assembled
by Hudson Control Group, Inc., Springfield, NJ. This fully
integrated automated plasmid-based functional pro-
teomic workcell is capable of performing the following
operations: 1) plate filling, 2) colony picking and arraying
in multiplexed wells, 3) large-scale plasmid preparation,
4) protein expression, and 5) functional protein assays.
Protocols for using the liquid handler component of the
workcell for plasmid preparation and plasmid analysis
have been described previously [12]. Plasmids were ana-
lyzed on the workcell, by adding samples from the Matrix
collection plate to a UV optically clear 96-well VWR
microplate, and measuring the absorbance at 230 nm,
260 nm and 280 nm in the Bio-Tek UV/VIS microplate
reader (Figure 1 #6). Additional spectrographic analysis of
plasmid samples was performed using the NanoDrop
ND-1000 fiber optic spectrophotometer (NanoDrop
Technologies) to develop a factor to adjust for variances in
the height of the readings taken by the UV/VIS microplate
reader. Plasmids were digested with BsrGI and the plas-
mid preparations were run on 2% agarose gels with ethid-
ium bromide (Sigma) added to visualize the DNA. The gel
was photographed with an Alpha Imager 3400 using soft-
ware version IS-3400 V 3.1.2 for Windows 2000/XP. Plas-
mids were sequenced using a MJ Tetrad PCR machine
model PTC 225 with the Big-Dye Terminator V3.1
(Applied Biosystems) according to the manufacturer's
instructions and run on an ABI 3730 DNA Analyzer
(Applied Biosystems).
Preparation of cellulase F mutagenesis library
A mutagenized celF library was generated as described pre-
viously [12] using celF cDNA [15,16] (GenBank Accession
Number U97154) from the anaerobic fungus Orpinomyces
PC-2 as template. In addition, NNY libraries were gener-
ated in a similar fashion using primers with NNR in the
anti-sense strand. Methods for topoisomerase ligation of
mutagenized PCR products into pENTR D TOPO, trans-
formation into TOP 10 E. coli cells, subsequent plasmid
preparation, recombinationally subcloning inserts into
pEXP-1 DEST using LR clonase, transformation into E. coli
cells and plasmid preparation for use in in vitro transcrip-
tion/translation were described previously [12]. Here sub-
cloning into pEXP-1 DEST, transformation into E. coli
cells and plasmid preparation for in vitro transcription/
translation were performed in an automated fashion on
the workcell.
In vitro expression of cellulase F on multiplexed plasmid 
plate
A 5-µL aliquot of the pEXP-1 DEST plasmids prepared on
the liquid handler was used for in vitro transcription/trans-
lation reactions with E. coli lysate containing T7 polymer-
ase (RTS 100 Kit; Roche Applied Science) to generate
recombinant protein. Half reactions at 25 µL were per-
formed instead of the full reaction at 50 µL described in
the directions for the kit. Reactions were incubated for 10
hours at 30°C. Nine (9) µL of the samples were run in
Western blot analysis (as described previously [12]) and 5
µL of the reactions were spotted (unless otherwise noted
in the figure legends) for azo-CMC plate analysis using the
assay described previously [12]. Relative activity of the
enzyme was scored by measurement of the diameter or
integrated density values of the cleared zone.
Isolation of individual colonies from multiplexed cultures
Those multiplexed wells identified by the screening azo-
CMC plate assay as containing mutant(s) with enhanced
glucanase activity were linked back to the glycerol stocksProteome Science 2006, 4:10 http://www.proteomesci.com/content/4/1/10
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containing the pEXP-1 DEST plasmids that gave rise to
these wells. Samples of the identified stocks were inocu-
lated onto LB AMP 50 86 × 128 mm spread plates capable
of being handled by the robot. The resulting individual
colonies, representing all the colonies that were inocu-
lated into each of the multiplexed wells, were either
picked manually or automatically for subsequent analy-
sis.
Manual picking of colonies into 96-well plate
Colonies from spread plates for the identified multiplexed
wells were picked manually and used to inoculate TB AMP
50 medium in a 96-well plate. The inoculated plate was
manually sealed with gas-permeable tape, taken to the
workcell shaker and incubated for 24 hours at 37°C and
150 rpm.
Automated picking of colonies into 96-well plate
The spread plates containing the colonies from the multi-
plex cultures were placed onto the workcell in the passive
stacker (Figure 1 #13). An ABgene 96-well deep well plate
was loaded into the active stacker, a 4-liter carboy contain-
ing 2 liters of TB AMP 50 medium was connected to the
Hudson micro10 filler (Figure 1 #10), and the automated
protocol for picking colonies into the 96-well plate was
initiated. The ABgene 96-well deep well plate was sent
from the Track 2 active stacker (Figure 1 #2B) to the Hud-
son micro10 filler (position S3) and each well filled with
1.6 mL of TB AMP 50 medium and the plate moved to the
Track 2 Plate Crane StopLink position S2. The plate was
moved by the plate crane (Figure 1 #3) from position S2
to S1 and then sent to S6 for inoculation with each of the
four control cultures from the cold tube rack on the liquid
handler deck (Figure 1 #9) into the first 6 wells in the two
upper left hand rows in blocks of two or four using the
Hudson liquid handler. After the controls were added, the
plate was sent via a Hudson TrackLink (Figure 1 #1A) into
the deck space of the picker in StopLink position S4. From
this location the gripper tool of the picker (Figure 1 #4)
moved the deep well plate with medium into the picker
destination location and removed the lid to receive colo-
nies. Picking was performed using a Hudson SoftLinx
Western blot of in vitro expressed proteins generated on the workcell Figure 8
Western blot of in vitro expressed proteins generated on the workcell. Variants are identified by row (letter) and column 
(number) on the azo-CMC plate (Figures 6 and 7) and by method used to pick colonies, either manual (MP) or automated (AP). 
Colors of boxes above lanes correspond to colors of boxes around cleared zones for those variants on plates in Figures 6 and 
7. Wild-type CelF and CelF variants of similar length are at 47.7 kD. E5MP at 52.6 kD had a mutated stop codon resulting in a 
variant with 54 more amino acids than wild-type. Band for GUS is seen at 60 kD.Proteome Science 2006, 4:10 http://www.proteomesci.com/content/4/1/10
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adapted routine of the BioRad VersArray picker integrated
into the workcell. The spread plates for the identified wells
were moved from the Hudson passive stacker (Figure 1
#13) by the plate crane (Figure 1 #3) to S1. SoftLinx soft-
ware from Hudson was used to identify spread plate wells
as the plates were moved onto the deck of the picker pass-
ing the bar code reader on Track 1 (Figure 1 #1A and #15).
The plate was then moved to S4 where the gripper tool on
the picker took the colony plate into the lighted area of
the picker deck (Figure 1 #4). The CCD camera photo-
graphed the spread plate in the lighted area to record a
digital image for capture and recognition of stereotactic
coordinates for all colonies of the programmed size range.
The colonies were picked using four dedicated pins of the
16-pin picking head (Figure 1 #4) and inoculated, four
colonies at a time, in an S-shaped pattern into the 96-well
plate, randomly taking 20 colonies from each of the first
four spread plates and 4 colonies from the last spread
plate. The inoculated plate was taken from the destination
location to S1, picked up, placed into the Brandel RS3000
porous tape sealer (Figure 1 #8) and sealed with gas-per-
meable tape. The plate was moved to S2 and loaded into
the Liconic incubator (Figure 1 #12) at the modified Stop-
Link S5 and incubated for 30 hours at 37°C and 600 rpm.
Glycerol stocks and long-term storage cards were prepared
in the work area of the liquid handler (Figure 1 #9) from
these cultures after incubation.
Automated inoculation from 96-well plate into four 24-
well plates in quadruplicate (4 × 4 × 24 wells)
The protocol was carried out with a modified SoftLinx
integration routine (Figure 1 #14). Qiagen 24-well deep
well plates were loaded into the active stacker (Figure 1
#2B), a 4-liter sterile carboy containing 2 liters of TB AMP
50 medium was attached to the filler (Figure 1 #10) with
sterile tubing, and the automated protocol for liquid cul-
ture inoculation into 24-well plates was initiated. The 24-
well deep well plates were sent from the Track 2 active
stacker (Figure 1 #2B) to the micro10 filler (position S3)
and each well filled with 5 mL of TB AMP 50 medium. The
plates were moved from S3 to Track 2 position S2 then to
Track 1 position S1 using the Plate Crane EX (Figure 1 #3)
and sent via a Hudson TrackLink to position S6 and then
into the deck of the liquid handler unit (Figure 1 #9) of
the workcell using the gripper arm of the liquid handler.
Four 24-well plates at a time were inoculated with 20 µL
culture in each well in the image of the 96-well plate four
times to give quadruplicate sets of four 24-well plates rep-
resenting the controls and the 84 colonies picked. The
inoculated plates were taken to position S6 then moved to
S1 on Track 1, picked up by the plate crane, placed into
the porous tape sealer (Brandel RS3000) (Figure 1 #8) on
the workcell and each plate sealed with gas-permeable
tape. All of the plates were moved to position S2 on Track
2 and then to S6 and into the Liconic incubator for 30
hours at 37°C and 600 rpm. Large-scale plasmid prepara-
tion was then carried out on the liquid handler as
described previously [12]. These plasmids were eluted on
the workcell into one Matrix 2D bar-coded collection
plate, samples placed in a UV/VIS microplate (Figure 1
#6), and the concentrations adjusted for consistent
expression.
Automated in vitro protein production
MJ plates and UV/VIS optically clear standard microplates
were placed into the active stacker (Figure 1 #2A). Protein
reagent was filled into Matrix 2D bar-coded tubes and
placed into the cold reagent position on the liquid han-
dler (Figure 1 #9) for holding at 2°C. The protocol for
protein production adapted from SoftLinx, accessing XAP
routines for reaction set up and spotting (Figure 1 #14),
was initiated. Protein reactions were prepared from plates
of plasmid on the deck of the liquid handler, then a new
MJ plate was moved from the active stacker to S6 on the
liquid handler deck and transported by the liquid handler
gripper to the cold block for reagent additions. The rea-
gents were mixed by aspiration and the plate moved to S6
then to position S1 for transport by the plate crane into
the ABgene 300 foil heat sealer (Figure 1 #7) and finally
into the PCR thermal cycler (Figure 1 #5). After the plas-
mids were obtained using the automated plasmid prepa-
ration protocol for large-scale plasmid preparation, 5-µL
aliquots of the pEXP-1 DEST mutagenized library plas-
mids were used for in vitro transcription/translation reac-
tions with the E. coli lysate containing T7 polymerase from
an RTS 100 Kit (Roche Applied Science) to generate
recombinant protein. Half reactions at 25 µL (5 µL of plas-
mid from plasmid preparations were used instead of 10
µL) were performed instead of the full 50-µL reaction
Comparison of activities of wild-type CelF and CelF mutant  proteins in integrated density values (IDV) as a function of  concentration on azo-CMC plate at pH 4 Figure 9
Comparison of activities of wild-type CelF and CelF mutant 
proteins in integrated density values (IDV) as a function of 
concentration on azo-CMC plate at pH 4.0 incubated 10 
hours at 37°C. Inset is Western blot analysis (with 50 kD 
marker) showing all proteins are present at the same con-
centration.Proteome Science 2006, 4:10 http://www.proteomesci.com/content/4/1/10
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described in the directions for the kit. This half reaction
supplied enough expressed protein for cellulase assays
and for Western blot analysis. Reactions were incubated
according to directions for 10 hours at 30°C in the PCR
thermal cycler after sealing with foil tape. The temperature
was then held at 4°C until azo-CMC plate spotting could
begin.
Temperature and pH evaluations of expressed protein 
using automated azo-CMC plate assay
For pH activity profiles, four azo-CMC plates at varying
pH (5.8, 5.0, 4.5, and 4.0) were loaded into the passive
stacker (Figure 1 #13), de-lidded by the gripper arm of the
plate crane (Figure 1 #3) and moved to S1, then to S6 into
the working area of the liquid handler (Figure 1 #9) for
the automated azo-CMC plate assay. The plate crane
moved the 96-well hardshell plate containing the in vitro
produced protein from the PCR thermal cycler (Figure 1
#5) to S1. From this position the plate was taken to S6 so
that the liquid handler gripper could place it into the cold
plate position on the deck, then into the jig position for
piercing and finally back to the cold position on the deck.
A SoftLinx-initiated XAP protocol was used to spot protein
on the azo-CMC plates for the assay using the pipet arm
of the liquid handler. Plates were moved to S6 with the
gripper, then sent to S1 to be picked up by the plate crane
and placed on S2. The plates were moved to S5 for loading
into the incubator. For evaluation of temperature stabil-
ity, the hardshell plate with protein was moved to the PCR
thermal cycler (Figure 1 #5), incubated at 50°C for one
hour then moved back to the cold position on the liquid
handler deck. A new pH 5.8 azo-CMC plate was moved
into the working area, spotted with the heated proteins,
and moved to the Liconic incubator with the other azo-
CMC plates. All the plates were incubated at 37°C for 10
hours. Plates were moved to the out stack on the passive
stacker and photographed using the Alpha Innotech 3400
digital imaging station.
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